Outset Medical, Inc. (OM)
Automate Your Wheel Strategy on OM
With Tiblio's Option Bot, you can configure your own wheel strategy including OM - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OM
- Rev/Share 2.2189
- Book/Share 3.2698
- PB 5.3857
- Debt/Equity 0.5779
- CurrentRatio 8.3733
- ROIC -0.3468
- MktCap 312089703.0
- FreeCF/Share -1.862
- PFCF -3.2262
- PE -8.0381
- Debt/Assets 0.3259
- DivYield 0
- ROE -1.454
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Outset Medical to Present at RBC Global Healthcare Conference
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate at the RBC Capital Markets Global Health Care conference on Tuesday, May 20, 2025, at 10:30 a.m. Eastern time.
Read More
Outset Medical, Inc. (OM) Reports Q1 Loss, Tops Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Outset Medical, Inc. (OM) came out with a quarterly loss of $3.24 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $8.55 per share a year ago.
Read More
OUTSET MEDICAL ALERT: Bragar Eagel & Squire, P.C. is Investigating Outset Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: April 29, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Outset Medical, Inc. (NASDAQ:OM) on behalf of long-term stockholders following a class action complaint that was filed against Outset Medical on August 29, 2024 with a Class Period from August 1, 2022 to August 7, 2024. Our investigation concerns whether the board of directors of Outset Medical have breached their fiduciary duties to the company.
Read More
Does Outset Medical (OM) Have the Potential to Rally 71.66% as Wall Street Analysts Expect?
Published: April 21, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at a 71.7% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
Wall Street Analysts Predict an 188.63% Upside in Outset Medical (OM): Here's What You Should Know
Published: April 02, 2025 by: Zacks Investment Research
Sentiment: Positive
The consensus price target hints at an 188.6% upside potential for Outset Medical (OM). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Read More
Bears are Losing Control Over Outset Medical (OM), Here's Why It's a 'Buy' Now
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Negative
Outset Medical (OM) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
3 Cryptocurrencies That Could Be Better Buys Than Bitcoin Right Now
Published: February 26, 2025 by: The Motley Fool
Sentiment: Positive
In 2025, Bitcoin (BTC -1.18%) has over-promised and under-delivered. After reaching $100,000 in December, Bitcoin looked like a no-brainer option to soar in value this year.
Read More
Outset Medical, Inc. (OM) Q4 2024 Earnings Call Transcript
Published: February 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Outset Medical, Inc. (NASDAQ:OM ) Q4 2024 Earnings Conference Call February 19, 2025 5:00 PM ET Company Participants Jim Mazzola - Head of Investor Relations Leslie Trigg - Chair and CEO Nabeel Ahmed - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Shagun Singh - RBC Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to the Outset Medical Fourth Quarter 2024 Earnings Conference Call.
Read More
Outset Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN JOSE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read More
Outset Medical Announces Resolution of Warning Letter
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced it has been notified by the Food and Drug Administration that all issues cited in a Warning Letter the company received in July of 2023 have been addressed.
Read More
About Outset Medical, Inc. (OM)
- IPO Date 2020-09-15
- Website https://www.outsetmedical.com
- Industry Medical - Devices
- CEO Ms. Leslie L. Trigg
- Employees 354